[Hybrid CME/CPE] Real-World Outcomes and Clinical Development of Lurbinectedin in 1L & 2L Small Cell Lung Cancer

Date and Time:
Thursday, 27th June 2024  | 6:30PM – 8:00PM SGT

  • 1 Cat 1B CME point will be awarded for Doctors (claimed by organizer).
  • 1 Cat 1A CPE point will be awarded for Pharmacists (self-claimed by pharmacists).

You must be healthcare professional to view this content.

POMConnect Banner2 Email Bottom